Relevant bibliographies by topics / Coinfected

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers

Academic literature on the topic 'Coinfected'

Author: Grafiati
Published: 4 June 2025
Last updated: 1 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Coinfected.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Coinfected"

1

Tural, Cristina, Josep Antón Galeras, Ramon Planas, et al. "Differences in Virological Response to Pegylated Interferon and Ribavirin between Hepatitis C Virus (Hcv)-Monoinfected and HCV–Hiv-Coinfected Patients." Antiviral Therapy 13, no. 8 (2008): 1047–55. http://dx.doi.org/10.1177/135965350801300818.

Full text
Abstract:
Background Suboptimal doses of ribavirin have been suggested to explain the diminished efficacy of pegylated interferon (PEG-IFN) plus ribavirin in hepatitis C virus (HCV)–HIV-coinfected patients. Methods A cohort of 104 coinfected patients and an age-, sex- and genotype-matched cohort of HCV-monoinfected patients ( n=104) were compared. All patients received PEG-IFN-α2a 180 μg/week plus ribavirin 800–1,200 mg daily (HCV genotype 2/3 patients received 800 mg daily and those with genotype 1/4 received 1,000–1,200 mg daily) for 48 weeks (24 weeks for monoinfected patients with genotypes 2/3). HC
APA, Harvard, Vancouver, ISO, and other styles
2

TOVO, Cristiane Valle, Smile Calisto da Costa BECKER, Paulo Roberto Lerias de ALMEIDA, Bruno GALPERIM, and Silvia CHAVES. "PROGRESSION OF LIVER FIBROSIS IN MONOINFECTED PATIENTS BY HEPATITIS C VIRUS AND COINFECTED BY HCV AND HUMAN IMMUNODEFICIENCY VIRUS." Arquivos de Gastroenterologia 50, no. 1 (2013): 19–22. http://dx.doi.org/10.1590/s0004-28032013000100005.

Full text
Abstract:
ContextThe progression of liver fibrosis in patients coinfected by hepatitis C virus and human immunodeficiency virus (HCV/HIV) has been increasingly studied in the past decade. Studies made before the highly active antiretroviral therapy suggest that HIV can change the natural history of the HCV infection, leading to a faster progression of the liver fibrosis.ObjectiveTo evaluate and compare the fibrosis progression in two groups of patients (HCV/HIV coinfected and HCV monoinfected)MethodsSeventy patients HCV monoinfected and 26 patients HCV/HIV coinfected who had not undertaken HCV treatment
APA, Harvard, Vancouver, ISO, and other styles
3

Brites, Carlos, Fernanda Miranda, Estela Luz, and Eduardo Martins Netto. "Early and Successful Combination Antiretroviral Therapy Normalizes Survival Time in Patients Coinfected With Human Immunodeficiency Virus and Human T-cell Lymphotrophic Virus Type 1." Clinical Infectious Diseases 71, no. 1 (2019): 196–200. http://dx.doi.org/10.1093/cid/ciz756.

Full text
Abstract:
Abstract Background Coinfection with human T-cell lymphotrophic virus type 1 (HTLV-1) is associated with shorter survival for adults and children infected with human immunodeficiency virus (HIV), although the reasons remain a matter of debate. We evaluated the factors associated with survival time in a large cohort of HIV/HTLV-1–coinfected and HIV-monoinfected individuals on combination antiretroviral therapy (cART). Methods In a nested, retrospective case-control study (1:1), we reviewed medical records of people with HIV infection on cART in a referral AIDS center in Salvador, Brazil. We mat
APA, Harvard, Vancouver, ISO, and other styles
4

Korolevskaya, L. B., E. V. Saidakova, V. V. Vlasova, and C. V. Shmagel. "State of CD4+ T-lymphocytes mitochondria in HIV/HCV coinfected patients with different efficiency of immune system restoration during antiretroviral therapy." HIV Infection and Immunosuppressive Disorders 13, no. 3 (2021): 52–60. http://dx.doi.org/10.22328/2077-9828-2021-13-3-52-60.

Full text
Abstract:
Objective: to assess mitochondrial parameters in CD4+ T-cells of HIV/HCV coinfected patients with a discordant and standard response of the immune system to antiretroviral therapy.Materials and methods. HIV/HCV coinfected patients with discordant (n=21) and standard (n=20) response to treatment were examined. The control group comprised of 23 uninfected volunteers. In CD4+ T-cells, PGC-1a content, mitochondrial mass, and mitochondrial membrane potential were determined with flow cytometry.Results. In CD4+ T-cells of HIV/HCV coinfected subjects with standard and discordant response to treatment
APA, Harvard, Vancouver, ISO, and other styles
5

SILVEIRA, PATRICIA, SANDRA Y. G. MARIN, PATRICIA A. MOREIRA, et al. "Interactions ofPlasmodium juxtanucleareand chicken anaemia virus: establishing a model." Parasitology 140, no. 14 (2013): 1777–88. http://dx.doi.org/10.1017/s0031182013001170.

Full text
Abstract:
SUMMARYThe pathogensPlasmodium juxtanucleareand chicken anaemia virus (CAV) are easily transmitted and potentially harmful to chickens. In this study, we established an experimental model to investigate the effects of avian malaria caused byP. juxtanuclearein white leghorn specific-pathogen-free (SPF) chicks previously immunosuppressed with CAV. Parasitaemia, haematological variables and clinical and pathological parameters were determined in four different experimental groups: chicks coinfected by CAV andP. juxtanuclearestrain (Coinfected group), chicks exclusively infected by CAV (CAV group)
APA, Harvard, Vancouver, ISO, and other styles
6

Edwards, Robert Jeffrey, Selena Todd, Jonathan Edwards, Noreen Jack, and Gregory Boyce. "Prevalence of HTLV-1 and Hepatitis B Surface Antigen (HBsAg) Positivity among MSM Attending a Large HIV Treatment Centre in Trinidad." Viruses 16, no. 7 (2024): 1169. http://dx.doi.org/10.3390/v16071169.

Full text
Abstract:
HIV-1, Hepatitis B and HTLV-1 have similar risk factors and shared routes of transmission and MSM are disproportionately affected by HIV. The aim of the study was to determine the prevalence of HTLV-1 and HBsAg positivity at initial enrolment among MSM attending a large HIV Clinic in Trinidad. Chart reviews were conducted between 2 and 15 January 2024, among self-identified MSM and a comparative group of randomly selected self-identified heterosexual males where sociodemographic, clinical and laboratory data were collected and analysed using SPSS Version 25. During the period April 2002–31 Oct
APA, Harvard, Vancouver, ISO, and other styles
7

Holden, Kevin, Emir Hodzic, Sunlian Feng, Kimberly J. Freet, Rance B. Lefebvre, and Stephen W. Barthold. "Coinfection with Anaplasma phagocytophilum Alters Borrelia burgdorferi Population Distribution in C3H/HeN Mice." Infection and Immunity 73, no. 6 (2005): 3440–44. http://dx.doi.org/10.1128/iai.73.6.3440-3444.2005.

Full text
Abstract:
ABSTRACT Borrelia burgdorferi, the agent of Lyme disease, and Anaplasma phagocytophilum, the agent of human anaplasmosis, are both transmitted by Ixodes sp. ticks and may occasionally coinfect a host. The population distributions of tick-transmitted B. burgdorferi infection were assessed using quantitative PCR targeting the flaB gene of B. burgdorferi in the ear, heart base, quadriceps muscle, skin, and tibiotarsal joint tissue of C3H mice previously infected with A. phagocytophilum. Population distributions of Anaplasma infection were assessed by targeting the p44 gene. A. phagocytophilum in
APA, Harvard, Vancouver, ISO, and other styles
8

Pinot de Moira, Angela, Frances M. Jones, Shona Wilson, et al. "Effects of Treatment on IgE Responses against Parasite Allergen-Like Proteins and Immunity to Reinfection in Childhood Schistosome and Hookworm Coinfections." Infection and Immunity 81, no. 1 (2012): 23–32. http://dx.doi.org/10.1128/iai.00748-12.

Full text
Abstract:
Naturally occurring human immunity to both schistosomiasis and hookworm infection has been associated with IgE responses against parasite allergen-like proteins. Since the two helminths frequently coinfect the same individuals, there is growing advocacy for their concurrent treatment. However, both helminths are known to exert strong immunomodulatory effects; therefore, coinfected individuals could have immune responses different from those characteristically seen in monoinfected individuals. In this study, we measured changes in IgE, IgG1, and IgG4 responses to schistosome and hookworm antige
APA, Harvard, Vancouver, ISO, and other styles
9

Antonello, Vicente Sperb, Dimas Alexandre Kliemann, Breno Rigel Santos, and Cristiane Valle Tovo. "HAART and liver: is it safe?" Journal of Infection in Developing Countries 8, no. 11 (2014): 1444–50. http://dx.doi.org/10.3855/jidc.5012.

Full text
Abstract:
Introduction: Liver disease caused by hepatitis C virus (HCV) is a major cause of morbidity in HIV patients. This study investigates the possibility that chronic HCV increases the risk of hepatotoxicity after highly active antiretroviral therapy (HAART) initiation. Methodology: The data from 30 coinfected HIV/HCV and 35 HIV monoinfected patients between August 2008 and August 2010, since the start of HAART, were analyzed along with data from every three months, with clinical/laboratory evaluation until the end of twelve months. The aim of this study was to assess risk and incidence of hepatoto
APA, Harvard, Vancouver, ISO, and other styles
10

Utili, Riccardo, Rosa Zampino, Pasquale Bellopede, et al. "Dual or Single Hepatitis B and C Virus Infections in Childhood Cancer Survivors: Long-Term Follow-Up and Effect of Interferon Treatment." Blood 94, no. 12 (1999): 4046–52. http://dx.doi.org/10.1182/blood.v94.12.4046.

Full text
Abstract:
Abstract We conducted a long-term prospective study of 89 cancer survivor children who had acquired hepatitis B virus (HBV) and/or hepatitis C virus (HCV) during treatment for neoplasia, the aim being to evaluate the natural history of the diseases and the effect of interferon (IFN) treatment. Patients were followed up for a median period of 13 years (range, 8 to 20); 46 were infected by HBV, 11 by HCV, and 32 coinfected by HBV and HCV. A spontaneous clearance of hepatitis B surface antigen (HBsAg) occurred more frequently in coinfected patients (19%) than in the HBV-infected (2%; P = .004), w
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Coinfected"

1

King, S. "An investigation into the genetic variation of hepatitis C virus in patients coinfected with HIV." Thesis, University of Liverpool, 2015. http://livrepository.liverpool.ac.uk/2052665/.

Full text
Abstract:
Co-infection with HIV in patients with chronic HCV infection is a common occurrence, which accelerates disease progression and the rate of liver fibrosis. Current literature report conflicting results on the effect of HIV co-infection on HCV at the genetic level. This thesis sets out to further explore the genetic variation of HCV in this group of patients, and use new techniques which may impact upon the diagnosis and management of HCV. In resource-limited settings such as sub-Saharan Africa, there is a paucity of data concerning rates of active HCV infection in patients with HIV infection. T
APA, Harvard, Vancouver, ISO, and other styles
2

Henn, Guilherme Alves de Lima. "Characterization of Visceral Leishmaniasis in patients coinfected with HIV and factors associated with death and relapse." Universidade Federal do CearÃ, 2016. http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=16704.

Full text
Abstract:
Visceral Leishmaniasis (VL) is endemic in 70 countries, including Brazil, and Cearà stands out for the large number of reported cases. It is known that L. infantum infection accelerates progression to AIDS while immunosuppression caused by HIV allows uncontrolled replication of the parasite. However, it is not clear what factors are associated with unfavorable outcomes for coinfection. This study aimed to describe clinical and laboratory presentation with VL-HIV coinfection and to identify potential factors associated with relapse and death. VL patients were enrolled from SÃo Josà Hospital,
APA, Harvard, Vancouver, ISO, and other styles
3

Yeung, Man Wah. "Overcoming Hepatitis C: changes in quality of life, healthcare use and substance use in HIV-coinfected patients after antiviral therapy." Thesis, McGill University, 2014. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=121533.

Full text
Abstract:
Background: In chronic hepatitis C virus (HCV) mono-infection and HIV/ HCV co-infection, the goal of antiviral treatment is a sustained virologic response (SVR). Some clinical benefits of SVR have been identified among HIV co-infected patients. However, endpoints beyond liver-related outcomes have not been well documented in co-infected patients who often have concurrent problems. We examined changes in health-related quality of life (HRQOL), health service use and substance over time among patients treated for HCV, in particular SVR-achievers and non-responders. Methods: HIV/ HCV co-infected
APA, Harvard, Vancouver, ISO, and other styles
4

Yang, Manli [Verfasser], Thomas [Gutachter] Dandekar, and Thomas [Gutachter] Rudel. "Chlamydia trachomatis metabolism during infection and metatranscriptome analysis in Neisseria gonorrhoeae coinfected STD patients / Manli Yang ; Gutachter: Thomas Dandekar, Thomas Rudel." Würzburg : Universität Würzburg, 2019. http://d-nb.info/1215033753/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Adewumi, Olayinka Anthony. "Treatment outcomes in patients infected with multidrug resistant tuberculosis and in patients with multidrug resistant tuberculosis coinfected with human immunodeficiency virus at Brewelskloof Hospital." Thesis, University of the Western Cape, 2012. http://etd.uwc.ac.za/index.php?module=etd&action=viewtitle&id=gen8Srv25Nme4_8245_1375971752.

Full text
Abstract:
<p>Many studies have reported low cure rates for multidrug-resistant tuberculosis (MDRTB) patients and MDR-TB patients co-infected with human immunodeficiency virus (HIV). However, little is&nbsp<br>known about the effect of HIV infection and antiretroviral therapy on the treatment outcomes of MDR-TB in South Africa. Therefore, the objectives of the study are: to find out whether HIV infection&nbsp<br>and interactions between ARVs and second line anti-TB drugs have an impact on the following MDR-TB treatment outcomes: cure rate and treatment failure at Brewelskloof Hospital. MDR-TB&nbsp<br>pat
APA, Harvard, Vancouver, ISO, and other styles
6

Franco, Kelly Flory. "Hepatitis C virus (HCV) replication in vitroand the effect of HCV on human immunodeficiency virus (HIV-1) coreceptor usage and diversity in the coinfected patient." Cincinnati, Ohio : University of Cincinnati, 2007. http://rave.ohiolink.edu/etdc//view?acc_num=ucin1183474023.

Full text
Abstract:
Thesis (Ph.D.)--University of Cincinnati, 2007.<br>Advisor: Dr. Julie A.E. Nelson. Title from electronic thesis title page (viewed Dec. 22, 2009). Includes abstract. Includes bibliographical references.
APA, Harvard, Vancouver, ISO, and other styles
7

Shire, Norah J. "Boosting, Bagging, and Classification Analysis to Improve Noninvasive Liver Fibrosis Prediction in HCV/HIV Coinfected Subjects: An Analysis of the AIDS Clinical Trials Group (ACTG) 5178." Cincinnati, Ohio : University of Cincinnati, 2007. http://rave.ohiolink.edu/etdc/view.cgi?acc_num=ucin1172860066.

Full text
Abstract:
Thesis (Ph.D.)--University of Cincinnati, 2007.<br>Advisor: Charles Ralph Buncher. Title from electronic thesis title page (viewed April 23, 2009). Keywords: Coinfection; Boosting and bagging; Classification analysis; HIV; Viral hepatitis. Includes abstract. Includes bibliographical references.
APA, Harvard, Vancouver, ISO, and other styles
8

Franco, Kelly Flory. "Hepatitis C Virus (HCV) Replication In Vitroand the Effect of HCV on Human Immunodeficiency Virus (HIV-1) Coreceptor Usage and Diversity in the Coinfected Patient." University of Cincinnati / OhioLINK, 2007. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1183474023.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Harfouch, Sawsan. "Les paramètres immunologiques assiciés à la guérison spontanée et sous traitement de la phase aiguë de l'infection par VHC chez les patients coinfectés VHC/VIH." Paris 6, 2013. http://www.theses.fr/2011PA066745.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Yaya, Issifou. "Comportements de santé et styles de vie des patients coinfectés par le VIH et VHC : impact sur l'accès aux soins et l'évolution clinique de l'hépatite C." Thesis, Aix-Marseille, 2018. http://www.theses.fr/2018AIXM0750/document.

Full text
Abstract:
Objectifs : Les objectifs principaux de cette thèse sont les suivants : 1) analyse de l’évolution du profil épidémiologique des patients coinfectés VIH-VHC initiant le traitement de l’hépatite C; 2) l’évaluation de l’impact des comportements de santé et des styles de vie sur l’évolution clinique de la maladie Résultats : J’ai pu mettre en évidence que le profil des patients coinfectés VIH-VHC initiant un traitement de l’hépatite C a changé en France avec l’évolution des traitements.Mes travaux ont permis de montrer que, chez les patients coinfectés VIH-VHC, une consommation élevée de café (3 t
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Coinfected"

1

Wilson, Deanna. Hepatitis. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199976805.003.0035.

Full text
Abstract:
Hepatitis A (HAV) and E (HEV) viruses are spread via the fecal-oral route. Hepatitis B virus (HBV) exposure is via occupational or recreational activities. Hepatitis D virus (HDV; also spread parentally) can only coinfect or superinfect those with chronic HBV. Hepatitis C (HCV) transmission is predominantly parenteral; the highest risk group is injection drug users. Prodromal-period patients with acute hepatitis present with vague constitutional symptoms when serum transaminases peak, with elevated serum bilirubin and varying levels of hepatic protein synthesis impairment; during the icteric p
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Coinfected"

1

Dreyfuss, Gilles, Philippe Sindou, Philippe Hourdin, Philippe Vignoles, and Daniel Rondelaud. "Fasciola hepatica larval development within the intermediate host." In Fasciolosis, 2nd ed. CABI, 2021. http://dx.doi.org/10.1079/9781789246162.0002.

Full text
Abstract:
Abstract This book chapter focuses on host snail species and larval behavior forms in snails, and features of parasitic infections in naturally or experimentally infected snails, or in coinfected snails.
APA, Harvard, Vancouver, ISO, and other styles
2

Mondorf, W., C. Mondorf, M. Malagó, and C. E. Broelsch. "Liver Transplantation in a HIV/HCV coinfected Hemophilia A Patient." In 32nd Hemophilia Symposium Hamburg 2001. Springer Berlin Heidelberg, 2003. http://dx.doi.org/10.1007/978-3-642-18150-4_28.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Rockstroh, J. K. "Report on Experience in the Treatment of Hepatitis C in HIV-Coinfected Hemophiliacs." In 30th Hemophilia Symposium Hamburg 1999. Springer Berlin Heidelberg, 2001. http://dx.doi.org/10.1007/978-3-642-18240-2_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Shiffman, Mitchell L. "How Do I Treat a Patient Who Is Coinfected With Chronic Hepatitis B and C Viruses?" In Curbside Consultation of the Liver. CRC Press, 2024. http://dx.doi.org/10.1201/9781003523758-15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Sterling, Richard K. "Is There a Simple Way to Treat a Patient Who Is Coinfected With Hepatitis B Virus and HIV?" In Curbside Consultation of the Liver. CRC Press, 2024. http://dx.doi.org/10.1201/9781003523758-19.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Challener, Douglas W., and Jasmine R. Marcelin. "More Than One Problem." In Mayo Clinic Infectious Disease Case Review, edited by Larry M. Baddour, John C. O’Horo, Mark J. Enzler, and Rahul Kashyap. Oxford University Press, 2021. http://dx.doi.org/10.1093/med/9780190052973.003.0018.

Full text
Abstract:
Coinfection with HIV and hepatitis C virus (HCV) is common. Chronically coinfected persons have higher rates of cirrhosis, hepatic insufficiency, and hepatocellular carcinoma compared with HIV-negative individuals. Because of the high prevalence of HIV-HCV coinfection, all patients with HIV diagnoses should be screened for HCV infection. The primary therapeutic goal in patients with HIV-HCV coinfection is to eradicate the HCV and limit progression of liver disease and complications.
APA, Harvard, Vancouver, ISO, and other styles
7

DeLano, Warren L., and Brian C. Cunningham. "Rapid screening of phage displayed protein binding afinities by phage ELISA." In Phage Display. Oxford University PressOxford, 2004. http://dx.doi.org/10.1093/oso/9780199638734.003.0005.

Full text
Abstract:
Abstract Monovalent phage display enables a single protein (or peptide) molecule to be presented on the surface of a phage particle. This protein is translated from a phagemid vector as a fusion linked to the natural pIII coat protein in an Escherichia coli cell coinfected with helper phage. The display achieves monova- lency since the fusion protein rarely substitutes for the native pIII protein from the helper phage genome. While display can be highly variable, typically just 0.05-5% of these phages actually display the protein of interest (1).
APA, Harvard, Vancouver, ISO, and other styles
8

Shmagel, Konstantin, and Evgeniya Saidakova. "Immune Disorders in HIV-Infected Patients Coinfected with Hepatitis C Virus." In Advances in HIV and AIDS Control. IntechOpen, 2018. http://dx.doi.org/10.5772/intechopen.76810.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Rockstroh, Jürgen Kurt, and Karine Lacombe. "How to Manage Hepatitis B Virus in the HIV Coinfected Patient." In Infectious Diseases. Elsevier, 2017. http://dx.doi.org/10.1016/b978-0-7020-6285-8.00225-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Rockstroh, Jürgen Kurt, and Karine Lacombe. "How to Manage Hepatitis C Virus in the HIV Coinfected Patient." In Infectious Diseases. Elsevier, 2017. http://dx.doi.org/10.1016/b978-0-7020-6285-8.00226-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Coinfected"

1

Pereira, Jéssica, José Barros, Carlos Brandão, Vanessa Paula, and Caroline Soares. "Human pegivirus challenge: detection and molecular characterization in HCV/HIV coinfected individuals." In IV International Symposium on Immunobiologicals & VII Seminário Anual Científico e Tecnológico. Instituto de Tecnologia em Imunobiológicos, 2019. http://dx.doi.org/10.35259/isi.sact.2019_32865.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Melo, Márcio Cristiano de, and Maria Rita Donalisio. "Lb3.248 Factors associated with survival of patients coinfected with aids and hcv." In STI and HIV World Congress Abstracts, July 9–12 2017, Rio de Janeiro, Brazil. BMJ Publishing Group Ltd, 2017. http://dx.doi.org/10.1136/sextrans-2017-053264.483.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Kiani, A. Z., A. R. Reihani, A. Medani, and A. Perumbeti. "Pulmonary Cavitation Found to Be Coinfected With Mycobacterium Tuberculosis and Coccidioides Immitis." In American Thoracic Society 2023 International Conference, May 19-24, 2023 - Washington, DC. American Thoracic Society, 2023. http://dx.doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a2045.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Maddali, R., J. Raynor, K. Cervellione, and L. Lew. "Coinfected with SARS-CoV-2 and Influenza B: A 2-Week-Old Presenting with Apnea." In American Thoracic Society 2021 International Conference, May 14-19, 2021 - San Diego, CA. American Thoracic Society, 2021. http://dx.doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3405.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Grønningen, Erlend, Lisbet Sviland, Ester Ngadaya, et al. "Utility of MPT64 antigen detection test for diagnosis of HIV coinfected extrapulmonary tuberculosis in Tanzania." In ERS International Congress 2019 abstracts. European Respiratory Society, 2019. http://dx.doi.org/10.1183/13993003.congress-2019.pa560.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Chromy, D., P. Schwabl, T. Bucsics, et al. "Impact of SVR to IFN-free DAA regimens on steatosis in HIV/HCV coinfected patients." In 51. Jahrestagung & 29. Fortbildungskurs der Österreichischen Gesellschaft für Gastroenterologie & Hepatologie (ÖGGH). Georg Thieme Verlag KG, 2018. http://dx.doi.org/10.1055/s-0038-1654663.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Margusino-Framiñan, L., C. Mondelo-Garcia, V. Gimenez-Arufe, et al. "5PSQ-040 Real-life direct-acting antivirals effectiveness comparative study in HIV-hepatitis C virus coinfected patients." In 24th EAHP Congress, 27th–29th March 2019, Barcelona, Spain. British Medical Journal Publishing Group, 2019. http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.473.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Killer, Alexander, Smaranda Gliga, David Pullmann, et al. "HBV reactivation after start of bulevirtide mono-treatment for a HBV/HDV coinfected patient: a case report." In 39. Jahrestagung der Deutschen Arbeitsgemeinschaft zum Studium der Leber. Georg Thieme Verlag, 2023. http://dx.doi.org/10.1055/s-0042-1760054.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Ferreira, Gislaine Curty, Costa Rl, Siqueira Jd, et al. "P1.20 Analysis of bacterial diversity in hiv/hpv coinfected patients with cervical intraepithelial lesions through next-generation sequencing." In STI and HIV World Congress Abstracts, July 9–12 2017, Rio de Janeiro, Brazil. BMJ Publishing Group Ltd, 2017. http://dx.doi.org/10.1136/sextrans-2017-053264.128.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Colletier, K., and A. Tanase. "Diagnosis and Successful Supportive Treatment of Respiratory Failure in a Patient Coinfected with Eastern Equine Encephalitis Virus and Metapneumovirus." In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a6609.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Coinfected' for particular source types:
Journal articles Dissertations / Theses
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography